Laurus Labs Limited has informed the Exchange about Schedule of meet

Board & Shareholder Meetings View source PDF

LAURUSLABS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

+0.3%1-day move

₹1381.80

prior close

₹1364.40

base price

In-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

-0.2+0.1——+0.3-0.1+0.9+3.5+4.6+2.7+2.1+7.9——

Up moveDown movePending

AI summary

Laurus Labs Limited has disclosed its schedule for two upcoming investor conferences in Hyderabad. The company will participate in the BofA Healthcare Tour on June 05, 2026 and the Macquarie Healthcare Tour on June 10, 2026, both as in-person meetings. This filing is made under SEBI's Regulation 30 which mandates timely disclosure of investor interactions. The company has clarified that no Unpublished Price Sensitive Information (UPSI) will be shared during these meetings. The dates may be subject to change due to exigencies.

Likely market impact

This is a routine regulatory disclosure indicating standard investor relations activity. Participation in major institutional investor tours by BofA and Macquarie suggests continued institutional interest in the company. No direct impact on stock price is expected as no material information is being disclosed.